NYSEARCA:KURE KraneShares MSCI All China Health Care Index ETF (KURE) Price, Holdings, & News $16.75 -0.15 (-0.89%) As of 06/27/2025 04:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock About KraneShares MSCI All China Health Care Index ETF (NYSEARCA:KURE) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get KURE alerts:Sign Up Key Stats Today's Range$16.66▼$16.9150-Day Range$14.78▼$17.9852-Week Range$12.91▼$20.51Volume8,946 shsAverage Volume44,647 shsMarket Capitalization$89.61 millionAssets Under Management$89.40 millionDividend Yield1.07%Net Expense Ratio0.65%Aggregate RatingModerate Buy ETF OverviewThe KraneShares MSCI All China Health Care Index ETF (KURE) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index of large- and mid-cap Chinese stocks in the health care sector. KURE was launched on Feb 1, 2018 and is managed by KraneShares.Read More… KraneShares MSCI All China Health Care Index ETF ExpensesTypeKUREHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.78%0.56%0.56%0.51%0.53%Other Expenses0.01%0.47%0.56%0.59%0.56%Total Expense0.79%0.75%0.76%0.74%0.73%Fee Waiver-0.14%-0.67%-0.66%-0.71%-0.63%Net Expense0.65%0.60%0.63%0.58%0.60% Receive KURE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for KraneShares MSCI All China Health Care Index ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address KURE ETF News HeadlinesKURE: Capitalizing On China's Healthcare RevolutionJune 24, 2025 | seekingalpha.comNew Drivers For China Health Care: AI Med-Tech Innovation, Cancer Treatment, And Favorable Balance Of TradeMarch 18, 2025 | seekingalpha.comIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd. | Brownstone Research (Ad)KraneShares Bosera MSCI China A 50 Connect Index ETF (KBA) Dividend HistoryMarch 2, 2025 | nasdaq.comChina Market Update: The Tale Of Two China’s & Their Investors Returns!November 11, 2024 | forbes.comAmundi MSCI World Health Care UCITS ETF EUR Acc (LYXHLTW)October 8, 2024 | investing.comSee More Headlines KURE ETF - Frequently Asked Questions How have KURE shares performed this year? KraneShares MSCI All China Health Care Index ETF's stock was trading at $14.19 on January 1st, 2025. Since then, KURE stock has increased by 18.0% and is now trading at $16.75. View the best growth stocks for 2025 here. How do I buy shares of KraneShares MSCI All China Health Care Index ETF? Shares of KURE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of KraneShares MSCI All China Health Care Index ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that KraneShares MSCI All China Health Care Index ETF investors own include Alibaba Group (BABA), NVIDIA (NVDA), Meta Platforms (META), PayPal (PYPL), Visa (V), Micron Technology (MU) and Tesla (TSLA). Fund Details IssuerKraneShares Fund NameKraneShares MSCI All China Health Care Index ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:KURE Inception Date1/31/2018 Fund ManagerMark Schlarbaum WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkMSCI China All Shares Health Care 10/40 Index CategorySector FocusHealth Care Development LevelEmerging Markets RegionAsia-Pacific Number of Holdings54 Fund Statistics Assets Under Management$89.40 million Average Daily Volume$36.71 thousand Discount/Premium0.04% Administrator, Advisor and Custodian AdministratorSEI Investments Global Funds Services AdvisorKrane Funds Advisors, LLC CustodianBrown Brothers Harriman & Co. DistributorSEI Investments Distribution Co. Transfer AgentBrown Brothers Harriman & Co. TrusteeN/A Lead Market MakerGTS Options OptionableOptionable Options Volume10 Put Options1 Call Options10 Short Interest157,700 shs Miscellaneous Outstanding Shares5,350,000Beta0.49 Creation Unit50,000 Creation Fee$1,320.00 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free Report Top 10 KURE HoldingsBEIGENE LTDHolding Weight: 9.19%Jiangsu Hengrui Medicine Co., Ltd.Holding Weight: 7.75%WuXi Biologics (Cayman) Inc.Holding Weight: 6.43%Shenzhen Mindray Bio-Medical Electronics Co., Ltd.Holding Weight: 6.24%CSPC Pharmaceutical Group LimitedHolding Weight: 4.85%Innovent Biologics, Inc.Holding Weight: 4.63%Akeso, Inc.Holding Weight: 4.24%Sino Biopharmaceutical LimitedHolding Weight: 4.16%WuXi AppTec Co., Ltd.Holding Weight: 3.12%Zhangzhou Pientzehuang Pharmaceutical., LtdHolding Weight: 2.82%Full Holdings DetailsKURE Sector ExposureKURE Industry Exposure This page (NYSEARCA:KURE) was last updated on 6/30/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… And it's all thanks to President Trump. His ...InvestorPlace | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored“Trump’s 24-Hour Profit Windows” revealedTrading legend Larry Benedict has discovered a repeating surge of $240 billion (and more)... Flowing into a...Brownstone Research | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KraneShares MSCI All China Health Care Index ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share KraneShares MSCI All China Health Care Index ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
